Download Files:
TCIP 1
SKU
HY-156531-10 mg
Category Reference compound
Tags BCL6;Epigenetic Reader Domain, Cancer, Epigenetics;Immunology/Inflammation
$588 – $4,800
Products Details
Product Description
– TCIP 1 is a transcriptional/epigenetic CIPs (TCIP) small molecule consisting of covalent links to small molecules capable of binding to BCL6 and capable of binding to BRD4, respectively. TCIPs aids cell death gene expression by recruiting endogenous cancer drivers or downstream transcription factors to the promoters of cell death genes. TCIP 1 also plays a gain-of-function mechanism with shows cell specificity and tissue specificity. TCIP 1 forms a gain-of-function ternary complex with BCL6 and BRD4, Inhibits the blocking effect of BCL6 on apoptosis gene, and generates transcriptional extension of pro-apoptotic genes, thus activates apoptosis. TCIP 1 also significantly inhibits the expression of the oncogene MYC and inhibits the growth of diffuse large B-cell lymphoma (DLBCL)[1].
Web ID
– HY-156531
Shipping
– Room temperature
Applications
– Cancer-programmed cell death
Molecular Formula
– C50H58Cl2N12O6S
References
– [1]Gourisankar S, et al. Rewiring cancer drivers to activate apoptosis. Nature. 2023 Jul 26.
Molecular Weight
– 1026.04
SMILES
– O=C(C1CCN(C2=NC=C(Cl)C(NC3=CC4=C(N(C)C(C(OCC(NC)=O)=C4)=O)C(OC)=C3)=N2)CC1)NCCCCCCCNC(C[C@H]5C6=NN=C(C)N6C7=C(C(C)=C(C)S7)C(C8=CC=C(Cl)C=C8)=N5)=O
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– 10 mM in DMSO
Target
– BCL6;Epigenetic Reader Domain
Isoform
– BRD4
Pathway
– Epigenetics;Immunology/Inflammation
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.